Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary ...

New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis with the ...

Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid crisis. This comes after a previous deal was rejected by the ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

SEATTLE — After a clumsy first half, Purdue basketball stormed back for an emphatic Big Ten road victory Wednesday. The Boilermakers extended their winning streak to six with a 69-58 victory ...

Assuming they all win approval, the clutch of potential new drugs could collectively generate peak sales between $10 billion and $20 billion—representative of roughly one-third to two-thirds of ...

But since a Dec. 29 win over Toledo, Purdue has looked like a completely different team. Meacham said a lot of credit goes to star point guard Braden Smith, who was the Big Ten Preseason Player of ...